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Abstract
Bioassays are useful tools in modern biosciences. The applications include development of new drugs; measurement of
biological activity in undefined substances; investigation of endogenous mediator function; determination of drug toxicity; and
measurement of the concentration of known substances such as pollutants or herbal products. As medicinal plants are very
popular on market, the safety and/or quality control of these phytotherapeutic agents become an important issue. Currently,
botanical identification, molecular identification and chemical analysis are often utilized for the quality analysis of plant
products. However, the methods are not totally reliable due to factors such as seasonal and geographical variations in plant
growth. An important development of herbal product quality analysis has been the use of biological assay systems which can
test many samples for activity in a short period of time. The advantages of using bioassays in this aspect are many-fold. The
tests can avoid the ethical and financial constraints of using human subjects or larger animals. Bioassay-guided isolation of
‘active’ compounds can be achieved and much smaller amount of test material is needed. However, it is important to realize
that there is no single method to assure absolute quality. Bioassays combined with plant macro and microscopic data, chemical
profiling and DNA fingerprinting would probably offer the safest and most efficacious herbal products.
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INTRODUCTION

QUALITY ANALYSIS OF HERBAL PRODUCTS

The term “bioassay” is a common short form for
“biological assay”. Bioassay can be defined as those tests
which are used to detect the biological or functional activity of an extract or pure substance from herbs and/or natural
products using the living organism, tissue or cell. Bioassay may be used for qualitative and/or quantitative characterizations. Qualitative bioassays are used for assessing
the biological effects of a substance that may not be quantified, such as abnormal development or deformity. Quantitative bioassays involve the estimation of effective concentration or potency of a substance by measurement of the
biological response that it produces. Bioassays are essential tools in the development of new drugs. Additionally,
important applications of bioassay include: measurement
of the biological activity of undefined substances; investigation of the functions of endogenous mediator; determination of the side-effect profile, including the degree of
drug toxicity; measurement of the concentration of known
substances; and assessing the amount of pollutants being
released by a particular source.

Medicinal plants have become very popular as
botanical supplements in recent years. Herbal products
are gaining an important share on the global pharmaceutical market. In the United States, it was estimated
that expenditures for alternative medicine professional
services increased 45.2% between 1990 and 1997 and
Americans consumed $5.1 billion dollars worth of herbal
medicine in 1997(1). Thus, the quality control of these
phytotherapeutic agents is an important issue. Reliable
authentication procedures for plant materials are critical
for the protection of both the public and industry. Several
methods are commonly employed for the quality analysis
of herbal products. Non-quantitative methods include:
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I. Botanical control using histological identification:
Macroscopic and microscopic examinations can be used
as rapid and inexpensive identification techniques (2).
II. Quality identification by chemical analysis: Measurement of the principal ingredient of the herbal extract is
a commonly used quantitative method. Chemical analysis is by far the best method for the detection of contam-
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DNA sequencing, PCR, AFLP, RFLP, RAPD, ISSR,
Biological chip

Identify ginseng by DNA-based protocol(5)
Identify niuzi from different area by RAPD(12)
Biological chip coupled with PCR technique was
developed for rapid authentication of ginseng
species(15)

Identify different species

Secondary metabolites can interfere or damage DNA

Spectrophotometry, TLC, CE, and HPLC

Identify Retinervus Citri Reticulatae and its confused species by
FTIR(29)
Twenty-two Shayuanzi samples collected from all over the country were
identified by TLC(30)
Characterization chemical compounds in Jin-Guo-Lan (Tinospora
sagittata and Tinospora capillipes) by HPLC(31)

Best way for contaminants detection and plant identification

Only detects chemicals that are present in plants
Misleading the Seasonal, environmental, individual variation among
plants or bastards

Identif ication of homonym dr ugs of
“Baitouweng” based on macroscopic identification and further study of microscopic
structures(28)

Rapid and inexpensive

Requires highly trained individuals
Limited references library for comparison

Example

Advantages

Limitations

III. Molecular identification: Molecular methods such as
those involving DNA sequencing(5), polymerase chain
reactions (PCR)(6), Amplified Fragment Length Polymorphism (AFLP)(7), Restriction Fragment Length Polymorphism (RFLP)(8), Random Amplified Polymorphic DNA
(RAPD)(9-12), Inter-Simple Sequence Repeat (ISSR)(13,14),
gene probes (or biological chip)(15) have been used for
herbal DNA identification(2,16-18).

Macroscopic and microscopic identification

Molecular identifacation

inants and can be an excellent method for plant identification(2). For example, in additional to microscopic
examination, one could use fluorescent or UV spectrophotometer, thin-layer chromatography (TLC), Capillary
electrophoresis (CE), or high-performance liquid chromatography (HPLC) to identify and determine the quality of
Smilax glabra Roxb (Tufuling)(3,4).

Methods
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In table 1, we show the classical identifications of
natural products and list the advantages as well as limitations. There are a number of shortcomings accompanying the use of these methods:

Chemical identification

I. Seasonal changes of plant may lead to changes in
compositions. For example, the chemical components
of essential oil from Baeckea frutescens collected from
different seasons have some different characteristics (19).
II. Different growing years of plants have different bioactivities. Dai et al. used thermokinetic parameters of
E. Coli metabolism to identify the quality of Rhizoma
Coptid in different growing years (20).
III. Regional variations in plant constituents can exist. It
has been demonstrated that there are significant differences in yield and quality of Scutellaria baicalensis from
different habitats. The crude drug from Pingyi (Shandong
province) is better than those from other habitats (21).

VI. Different manufacturing processes lead to products
with different biological effectiveness.

BIOASSAY FOR HERBAL PRODUCTS
An important development of drug discovery process
over the last several decades has been the use of biological assay systems which can test many samples for activity in a short period of time, thus providing enough data
for biostatistical analysis. Although clinical trials involving human subjects could be considered as bioassays in
the broadest sense, these are generally excluded from

Histological identification

V. The methods used in harvesting and storage affect the
herbal compositions.

Table 1. Classical identification of herbal products

IV. The principal ingredient may not be the most biological active component.
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this category. Depending on the methodology involved,
bioassays may be divided into “in vivo”, “ex vivo” or “in
vitro”. “Ex vivo” means living animal tissue is used; “in
vivo” means living animals are used. “In vitro” test is
used to investigate the effect of compounds or extracts
which do not involve either living animal tissue or whole
animals. In vitro tests commonly utilize cells, enzymes
or isolated receptors as targets for the substances under
test, but in some cases, small whole animals can be used,
e.g. the use of the nematode Caenorhabditis elegans for
anthelmintic studies (22).
The advantages of using bioassays for quality analysis of herbal products are many-fold:
I. The tests can avoid the ethical and financial constraints
of using human subjects or larger animals.
II. Bioassay-guided isolation of ‘active’ compounds can
be achieved.
III. Much smaller amount of test material is needed.
In the early days of development about three decades
ago, bioassays were used to study the extracts and/or
compounds for antibacterial and antifungal activity.
These were followed by cytotoxicity tests on mammalian
cells for discovering novel anticancer agents (23). More
recently, bioassays have been utilized in the quest for
antiviral agents including potential compounds for treating HIV(24). Although in vivo models give a more accu-

rate reflection of the activity of substances used in traditional medicine, their use in many countries is severely
restricted due to economic and ethical concerns, and
this has resulted in the widespread use of in vitro tests
in ethnopharmacological studies. Such tests are very
useful where the identity of compounds responsible for
the biological activity of an extract is being investigated
and where limited supplies of material are available. For
instance, in the development of agents used to treat type2 diabetes or NIDDM, a method of measuring insulin
release from pancreatic cells has been introduced whereby radioimmunoassay is used to measure insulin levels
after treating cultured islet cells with the test substances.
Thirty-two plant species for treating diabetes were put
to this test and three showed a stimulatory effect (25). An
ethanolic extract of Gymnema sylvestre, a species well
known for its antidiabetic properties, showed a significant increase in insulin secretion from three different
cultured islet beta-cell lines(26). In table 2, we further
conclude some in vitro and in vivo bioassays models of
natural products and give the specific example.
On the other hand, it is important to realize that for
any particular disease, multiple pathological factors
may be involved. The use of only one bioassay gives a
very incomplete picture of the effect of the extract on the
disease as a whole. A symptom may be due to a number of
disease states and, consequently, a variety of mechanisms
may serve as targets for bioassays. In a similar way, it is
very unusual for there to be only one target for a particu-

Table 2. Bioassay applied in quality and safety control of herbal products
Assays/ Measurements/ Models

Examples of application

In vitro
Reporter genes assay

One could screen the bioactivity of natural products by DNA manipulation and promoter
system. For example, curcumin is discovered as an inducer of the heat shock response by
reporter assay(32,33).

Advanced glycation end products (AGEs)
production

AGEs is related to diabetic complications. Jang et al measured the AGE production and
discovered Puerariafuran is an inhibitor of AGEs(34).

Phospholipid liposome peroxidation

Inhibition of phospholipid liposome peroxidation is a marker of antioxidation. Aruoma et
al used this marker to identify the antioxidant activity of Rosemary(35).

Anti-endotoxin effect

LPS induced cytokine gene, such as TNFα or IL-1, expression patterns are antiendotoxin markers. Detection of those changes of patterns would discover antiendotoxin components, Isatis indigotica or Rhizoma Chuanziong, for example, in herbal
products(36).

Cytotoxicity of cancer cell lines

The anti-cancer bioactivity of plant derived compounds could be tested by the IC50 of
various cancer cell lines(37).

In vivo
Hepatoprotection/ CCl4 induced liver damage

Carbon tetrachloride (CCl4) is used as a hepatotoxicant. Protein isolate of P. niruri
protects liver tissues against oxidative damage(38).

Diabetes/ STZ or fructose induced diabetic rats

Ginsenoside Rh2 is demonstrated as an ideal anti-diabetic medicine by either STZinduced type I diabetic or fructose-induced type II diabetic animal(39,40).

Hyperlipidemia/ High-fat diet induced
hyperlipidemia hamsters

Hypolipidemic effects of Monascus and Tamarindus indica L. were tested on
hyperlipidemic hamsters(41,42).

Angiogenesis/ Chick embryo chorioallantoic
membrane (CAM) model

CAM is an classical angiogenesis model (43). Epimedium sagittatum, Trichosanthes
kirilowii and Dalbergia odorifera showed the strong angiogenetic activity in CAM
model(44).
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lar disease so a variety of test systems must be employed.
Therefore, batteries of test systems used to test plants and
other materials for potential usefulness in wound-healing,
diabetes, cancer and dementia have been developed(27).

CONCLUSIONS
Authentication of herbal products is an important
issue for the protection of consumers. Safety and/or
quality control must be exerted throughout the various
processing stages, from the raw material to the finished
product. Bioassays have brought about a useful approach
to the quality analysis and development of herbal products for medicinal use. It can be anticipated that such
applications will continue to grow. However, it is very
important to realize the strength and limitation of these
tests. For example, one should not extrapolate results
from in vitro tests to claim clinical efficacy without
taking into account other biopharmaceutical factors.
Development of bioassay systems with batteries of tests
targeting a particular disease will overcome the current
shortcomings of using a single test. As for authentication
of herbal products, currently there is no single method to
assure absolute quality. Bioassays combined with plant
macro and microscopic data, chemical profiling and DNA
fingerprinting would probably offer the safest and most
efficacious herbal products.
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